About Us

Launched in 2015, the $35 million Intermountain Innovation Fund is a strategic investment vehicle of Intermountain Healthcare. Its purpose is to source, evaluate, and invest in innovative companies that represent a high return, high growth opportunity and that align with Intermountain’s mission of helping people live the healthiest lives possible®. The Fund is managed by Healthbox™, a partner for innovation and entrepreneurship in healthcare having worked with more than 35 healthcare organizations and over 160 early-stage companies since its founding in 2011. Caroline Arenz, Leland Brewster, Dr. Eric Louie, Neil Patel, and Jeffrey Ries oversee the Fund.

Investment Criteria

The Fund invests in healthcare IT companies with a strong provider angle that meet the following criteria:

  • Investment Size: Minimum investment of $1 million with a target of $3-5 million invested over the life of a portfolio company
  • Company Stage: Majority of investments will fall within Series A – C, but the fund is stage agnostic
  • Investment Scope: Capital efficient healthcare IT and services companies; pre-approval therapeutics, devices, and diagnostics will generally be considered out of scope ; limited consideration may be given to FDA approved, or otherwise low regulatory risk, devices and diagnostics.

Additionally, while a customer relationship is not a prerequisite for investment, all companies that seek to build a relationship with Intermountain–commercially, financially, or both–must show that they can improve outcomes and reduce costs.

Investments:

Current Portfolio

PierianDx

PierianDx

Founded in 2014, PierianDx enables clinical labs to deliver patient-specific diagnosis and treatments based on an individual’s DNA.
redox

Redox

Founded in 2014, Redox is the modern API for healthcare, allowing best-in-class software to easily and securely interoperate with EHRs in a health system infrastructure.
Syapse2full

Syapse

Founded in 2008, Syapse provides a precision medicine data platform enabling healthcare providers to use molecular profiling to diagnose and treat patients.
ZebraMed

Zebra Medical Vision

Founded in 2014, Zebra Medical Vision uses big data to deliver large scale clinical research platforms and next generation imaging analytics services to the healthcare industry.

Historical Portfolio

TuteGenomics

Tute Genomics

Founded in 2012, Tute Genomics is a cloud-based clinical genome interpretation platform that enables researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment.